Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

China flag China · Delayed Price · Currency is CNY
67.50
+0.36 (0.54%)
Sep 19, 2025, 2:45 PM CST
0.54%
Market Cap5.67B
Revenue (ttm)347.74M
Net Income (ttm)-27.25M
Shares Out83.87M
EPS (ttm)-0.29
PE Ration/a
Forward PEn/a
Dividend6.80 (10.06%)
Ex-Dividend DateSep 11, 2025
Volume1,637,175
Average Volume2,668,975
Open67.60
Previous Close67.14
Day's Range66.60 - 68.99
52-Week Range38.73 - 73.25
Beta0.42
RSI57.11
Earnings DateOct 24, 2025

About SHA:688399

Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. The company was founded in 2010 and is headquartered in Taizhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 592
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688399
Full Company Profile

Financial Performance

In 2024, SHA:688399's revenue was 349.61 million, a decrease of -13.29% compared to the previous year's 403.18 million. Losses were -2.00 million, -99.46% less than in 2023.

Financial Statements

News

There is no news available yet.